跳至主要内容
临床试验/NCT07323147
NCT07323147Enrolling By Invitation不适用

Clinical Efficacy of Exoskeleton Robot-Assisted Rehabilitation on Lower Limb Functional Recovery in Elderly Patients With Hip Fracture: A Multicenter, Open-Label, Randomized Controlled Clinical Trial

Hai bao1 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2026年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
86
试验地点
1
主要终点
Harris Hip Score

研究概览

简要总结

With the intensification of population aging, hip fracture, as a common bone disease, is seeing an increasing incidence rate among the elderly population. Traditional rehabilitation training methods can no longer fully meet the functional recovery needs of elderly patients with hip fractures. Due to their wearability and intelligence, exoskeleton robots provide an innovative solution for rehabilitation training. This study aims to explore the application effects of exoskeleton robots in postoperative rehabilitation for elderly patients with hip fractures by utilizing exoskeleton robot-assisted rehabilitation training for elderly hip surgery patients. The focus is on its improvements in motor ability, balance ability, and pain levels, while also assessing its impact on patients' overall quality of life and the prevention of complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
65 Years 至 100 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 65 years or older, regardless of gender.
  • Diagnosed with a unilateral hip fracture resulting from low-energy trauma by imaging (X-ray/CT), and having undergone surgical treatment (internal fixation or arthroplasty).
  • The participant or their legal guardian understands and agrees to participate in the clinical trial and is willing to provide voluntary written informed consent.

排除标准

  • Life expectancy of less than 6 months.
  • History of neurological disorders such as prior stroke, spinal cord injury, Parkinson's disease, or myasthenia gravis.
  • Severe joint contractures, deformities, or heterotopic ossification in the lower limbs that would prevent proper device fitting.
  • Body weight exceeding the device's maximum load capacity (>100 kg).
  • Height outside the adjustable range of the device.
  • Presence of a pathological fracture or multiple fragility fractures.
  • Presence of severe osteoarthritis or trauma in the contralateral lower limb that significantly impairs function.
  • Comorbidities including active malignancy or systemic infection.
  • Comorbidities such as thromboembolic disease in the lower limbs, pneumonia, or pressure injuries (bedsores).
  • Comorbidities affecting rehabilitation capacity, including unstable angina, heart failure, severe sequelae of stroke, severe chronic obstructive pulmonary disease (COPD), or severe hepatic/renal dysfunction.
  • Poor compliance, cognitive impairment preventing cooperation, or diagnosed psychiatric disorders such as depression or anxiety.
  • Participation in any other clinical trial within the 3 months prior to screening.

研究组 & 干预措施

Intervention Group

Experimental

Training with exoskeleton+Conventional rehabilitation program

干预措施: Exoskeleton (Device)

Control Group

Active Comparator

Conventional rehabilitation program

干预措施: Conventional rehabilitation program (Other)

结局指标

主要结局

Harris Hip Score

时间窗: 1-month post-intervention (T1), 3-month post-intervention (T2).

Assessed using the Harris Hip Score (HHS), a disease-specific instrument widely used for evaluating outcomes following hip surgery or in hip pathology. The scale assesses the patient across four domains: pain (44 points), function (47 points), range of motion (5 points), and absence of deformity (4 points). The total score ranges from 0 to 100 points. A higher score indicates better hip joint function and less disability. The reported value is the total HHS score (points).

次要结局

  • Berg Balance Scale(1-month post-intervention (T1), 3-month post-intervention (T2))
  • Timed Up and Go Test(1-month post-intervention (T1), 3-month post-intervention (T2).)
  • 6-Minute Walk Test(1-month post-intervention (T1), 3-month post-intervention (T2).)
  • Visual Analogue Scale (VAS)(1-month post-intervention (T1), 3-month post-intervention (T2).)
  • Range of Motion Measurement(1-month post-intervention (T1), 3-month post-intervention (T2).)
  • Psychological Assessment(Baseline (T0), 1-month post-intervention (T1), 3-month post-intervention (T2).)
  • Proteomics Analysis(Baseline (T0), 1-month post-intervention (T1), 3-month post-intervention (T2).)

研究者

发起方
Hai bao
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hai bao

Attending Physician

Beijing Jishuitan Hospital

研究点 (1)

Loading locations...

相似试验

Clinical Efficacy of Exoskeleton Robot-Assisted... | 临床试验